Liquidia Corp. (LQDA)
55.95
-0.68
(-1.20%)
USD |
NASDAQ |
Nov 20, 10:36
Liquidia Free Cash Flow : 291.15M for Sept. 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2026 | 291.15M |
| June 30, 2026 | 150.69M |
| March 31, 2026 | 41.15M |
| December 31, 2025 | -40.02M |
| September 30, 2025 | -104.33M |
| June 30, 2025 | -120.48M |
| March 31, 2025 | -103.89M |
| December 31, 2024 | -98.37M |
| September 30, 2024 | -92.46M |
| June 30, 2024 | -77.66M |
| March 31, 2024 | -59.52M |
| December 31, 2023 | -42.85M |
| September 30, 2023 | -31.76M |
| June 30, 2023 | -25.59M |
| March 31, 2023 | -28.22M |
| December 31, 2022 | -29.18M |
| September 30, 2022 | -31.67M |
| June 30, 2022 | -31.63M |
| Date | Value |
|---|---|
| March 31, 2022 | -31.49M |
| December 31, 2021 | -34.14M |
| September 30, 2021 | -40.69M |
| June 30, 2021 | -47.49M |
| March 31, 2021 | -52.71M |
| December 31, 2020 | -54.90M |
| September 30, 2020 | -54.96M |
| June 30, 2020 | -54.92M |
| March 31, 2020 | -54.40M |
| December 31, 2019 | -50.13M |
| September 30, 2019 | -44.37M |
| June 30, 2019 | -38.20M |
| March 31, 2019 | -32.80M |
| December 31, 2018 | -32.70M |
| September 30, 2018 | -30.23M |
| June 30, 2018 | -30.10M |
| March 31, 2018 | -28.00M |
| December 31, 2017 | -26.83M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| United Therapeutics Corp. | 863.80M |
| Johnson & Johnson | 19.98B |
| Eli Lilly & Co. | 11.69B |
| Mentari Therapeutics, Inc. | -7.839M |
| Corcept Therapeutics, Inc. | 194.62M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 146.68M |
| Cash from Investing (Quarterly) | -16.90M |
| Cash from Financing (Quarterly) | -17.87M |
| Free Cash Flow Per Share (Quarterly) | 1.450 |
| Free Cash Flow to Equity (Quarterly) | 143.91M |
| Free Cash Flow to Firm (Quarterly) | 132.33M |
| Free Cash Flow Yield | 5.80% |